vs
Alignment Healthcare, Inc.（ALHC）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Alignment Healthcare, Inc.的季度营收约是Rollins, Inc.的1.1倍（$1.0B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs -1.1%，领先13.0%），Alignment Healthcare, Inc.同比增速更快（44.4% vs 10.2%），Rollins, Inc.自由现金流更多（$111.2M vs $-55.4M），过去两年Alignment Healthcare, Inc.的营收复合增速更高（26.9% vs 0.8%）
Alignment Healthcare是总部位于美国的医疗保健企业，主打联邦医疗保险优势计划，为老年群体提供协调医疗服务、处方药保障及补充福利，采用价值导向医疗模式，与本土医疗机构合作，业务覆盖美国多个州，致力提升患者健康水平。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
ALHC vs ROL — 直观对比
营收规模更大
ALHC
是对方的1.1倍
$906.4M
营收增速更快
ALHC
高出34.2%
10.2%
净利率更高
ROL
高出13.0%
-1.1%
自由现金流更多
ROL
多$166.6M
$-55.4M
两年增速更快
ALHC
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $906.4M |
| 净利润 | $-11.0M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | -1.0% | 16.1% |
| 净利率 | -1.1% | 11.9% |
| 营收同比 | 44.4% | 10.2% |
| 净利润同比 | 64.6% | 2.5% |
| 每股收益（稀释后） | $-0.04 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALHCROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.0B | $912.9M | ||
| Q3 25 | $993.7M | $1.0B | ||
| Q2 25 | $1.0B | $999.5M | ||
| Q1 25 | $926.9M | $822.5M | ||
| Q4 24 | $701.2M | $832.2M | ||
| Q3 24 | $692.4M | $916.3M | ||
| Q2 24 | $681.3M | $891.9M |
净利润ALHCROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-11.0M | $116.4M | ||
| Q3 25 | $3.7M | $163.5M | ||
| Q2 25 | $15.7M | $141.5M | ||
| Q1 25 | $-9.1M | $105.2M | ||
| Q4 24 | $-31.1M | $105.7M | ||
| Q3 24 | $-26.4M | $136.9M | ||
| Q2 24 | $-24.0M | $129.4M |
营业利润率ALHCROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | -1.0% | 17.5% | ||
| Q3 25 | 0.8% | 21.9% | ||
| Q2 25 | 2.2% | 19.8% | ||
| Q1 25 | -0.6% | 17.3% | ||
| Q4 24 | -3.2% | 18.1% | ||
| Q3 24 | -2.8% | 20.9% | ||
| Q2 24 | -2.7% | 20.4% |
净利率ALHCROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | -1.1% | 12.8% | ||
| Q3 25 | 0.4% | 15.9% | ||
| Q2 25 | 1.5% | 14.2% | ||
| Q1 25 | -1.0% | 12.8% | ||
| Q4 24 | -4.4% | 12.7% | ||
| Q3 24 | -3.8% | 14.9% | ||
| Q2 24 | -3.5% | 14.5% |
每股收益（稀释后）ALHCROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $-0.04 | $0.24 | ||
| Q3 25 | $0.02 | $0.34 | ||
| Q2 25 | $0.07 | $0.29 | ||
| Q1 25 | $-0.05 | $0.22 | ||
| Q4 24 | $-0.15 | $0.22 | ||
| Q3 24 | $-0.14 | $0.28 | ||
| Q2 24 | $-0.13 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $604.2M | $116.5M |
| 总债务越低越好 | $323.2M | $650.6M |
| 股东权益账面价值 | $179.3M | $1.4B |
| 总资产 | $1.1B | $3.2B |
| 负债/权益比越低杠杆越低 | 1.80× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资ALHCROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $604.2M | $100.0M | ||
| Q3 25 | $644.1M | $127.4M | ||
| Q2 25 | $503.8M | $123.0M | ||
| Q1 25 | $479.5M | $201.2M | ||
| Q4 24 | $470.6M | $89.6M | ||
| Q3 24 | $381.0M | $95.3M | ||
| Q2 24 | $363.7M | $106.7M |
总债务ALHCROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $323.2M | $486.1M | ||
| Q3 25 | $322.7M | $485.7M | ||
| Q2 25 | $322.3M | $485.3M | ||
| Q1 25 | $321.9M | $485.5M | ||
| Q4 24 | $321.4M | $395.3M | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $211.7M | — |
股东权益ALHCROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $179.3M | $1.4B | ||
| Q3 25 | $161.9M | $1.5B | ||
| Q2 25 | $141.0M | $1.4B | ||
| Q1 25 | $108.1M | $1.4B | ||
| Q4 24 | $99.9M | $1.3B | ||
| Q3 24 | $114.5M | $1.3B | ||
| Q2 24 | $123.7M | $1.2B |
总资产ALHCROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $1.1B | $3.1B | ||
| Q3 25 | $1.1B | $3.2B | ||
| Q2 25 | $1.0B | $3.2B | ||
| Q1 25 | $895.6M | $2.9B | ||
| Q4 24 | $782.1M | $2.8B | ||
| Q3 24 | $692.3M | $2.8B | ||
| Q2 24 | $716.3M | $2.8B |
负债/权益比ALHCROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 1.80× | 0.35× | ||
| Q3 25 | 1.99× | 0.32× | ||
| Q2 25 | 2.29× | 0.34× | ||
| Q1 25 | 2.98× | 0.36× | ||
| Q4 24 | 3.22× | 0.30× | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.71× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-50.4M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $-55.4M | $111.2M |
| 自由现金流率自由现金流/营收 | -5.5% | 12.3% |
| 资本支出强度资本支出/营收 | 0.5% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $113.1M | $621.1M |
8季度趋势，按日历期对齐
经营现金流ALHCROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $-50.4M | $164.7M | ||
| Q3 25 | $144.6M | $191.3M | ||
| Q2 25 | $29.1M | $175.1M | ||
| Q1 25 | $16.6M | $146.9M | ||
| Q4 24 | $-8.7M | $188.2M | ||
| Q3 24 | $26.2M | $146.9M | ||
| Q2 24 | $23.5M | $145.1M |
自由现金流ALHCROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $-55.4M | $159.0M | ||
| Q3 25 | $139.1M | $182.8M | ||
| Q2 25 | $21.1M | $168.0M | ||
| Q1 25 | $8.4M | $140.1M | ||
| Q4 24 | $-18.0M | $184.0M | ||
| Q3 24 | $16.9M | $139.4M | ||
| Q2 24 | $11.8M | $136.4M |
自由现金流率ALHCROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | -5.5% | 17.4% | ||
| Q3 25 | 14.0% | 17.8% | ||
| Q2 25 | 2.1% | 16.8% | ||
| Q1 25 | 0.9% | 17.0% | ||
| Q4 24 | -2.6% | 22.1% | ||
| Q3 24 | 2.4% | 15.2% | ||
| Q2 24 | 1.7% | 15.3% |
资本支出强度ALHCROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 0.5% | 0.6% | ||
| Q3 25 | 0.6% | 0.8% | ||
| Q2 25 | 0.8% | 0.7% | ||
| Q1 25 | 0.9% | 0.8% | ||
| Q4 24 | 1.3% | 0.5% | ||
| Q3 24 | 1.3% | 0.8% | ||
| Q2 24 | 1.7% | 1.0% |
现金转化率ALHCROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | 38.77× | 1.17× | ||
| Q2 25 | 1.86× | 1.24× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
